全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2018 

miR-99a抑制物对骨肉瘤细胞生物行为学的影响 Effect of MiR-99a Inhibitor on the Biological Behavior of Human Osteosarcoma Cells

Keywords: 骨肉瘤,微小RNA-99a,侵袭转移,回复引导半胱氨酸丰富蛋白,基质金属蛋白酶

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:探索miR-99a在骨肉瘤中的表达情况及其对骨肉瘤细胞生物学行为特性的影响。方法:收集7例骨肉瘤组织及瘤旁骨组织,RT-PCR检测并比较miR-99a表达情况;RT-PCR技术检测miR-99a在骨肉瘤细胞系143B、MG-63和U2OS中的相对表达量,以人成骨细胞系hFOB1.19作为对照比较;RT-PCR检测hepG2、lovo、A549和MCF-7中的miR-99a相对表达量,以143B作对照比较。培养人骨肉瘤细胞系143B,瞬时转染miR-99ainhibitor后,CCK-8检测细胞增殖,流式细胞仪检测细胞凋亡,划痕试验检测细胞迁移,Transwell小室法检测细胞侵袭,Western Blot检测RECK、MMP-2、MMP-9蛋白的表达情况。结果:miR-99a在7例骨肉瘤组织中的相对表达量(0.81±0.06)要明显高于瘤旁骨组织(0.48±0.06)(P<0.01)。3组骨肉瘤细胞系miR-99a表达量均高于人成骨细胞hFOB1.19,差异有统计学意义(P<0.01);骨肉瘤细胞系中miR-99a相对表达明显高于四种非骨肉瘤细胞系(P<0.05)。miR-99ainhibitor转染组细胞增殖速率显著减慢,低于inhibitor-NC组和空白组(P<0.05);转染组早期凋亡和晚期凋亡均未明显增加(P>0.05);转染组细胞迁移能力明显受到抑制;转染组143B细胞穿过小室底膜的数目明显低于inhibitor-NC组和空白组(P<0.05);转染组RECK蛋白表达上调,MMP-2和MMP-9蛋白表达下调。结论:miR-99a在骨肉瘤组织和细胞系中呈现高表达,下调miR-99a能抑制骨肉瘤细胞系143B增殖、侵袭和转移能力,其机制可能是通过调控RECK/MMP-2蛋白表达而实现的

References

[1]  Mishra PJ.MicroRNAs as promising biomarkers in cancer diagnostics[J].Biomark Res,2014,2:19.
[2]  Chen C,Zhao Z,Liu Y,et al.microRNA-99ais downregulated and promotes proliferation,migration and invasion in non-small cell lung cancer A549and H1299cells[J].Oncol Lett,2015,9(3):1 128-1 134.
[3]  Jiang H,Qu L,Wang Y,et al.miR-99apromotes proliferation targeting FGFR3in human epithelial ovarian cancer cells[J].Biomed Pharmacother,2014,68(2):163-169.
[4]  Feng Y,Kang Y,He Y,et al.microRNA-99aacts as a tumor suppressor and is down-regulated in bladder cancer[J].BMC Urol,2014,14:50.
[5]  Calin GA,Croce CM.MicroRNA signatures in human cancers[J].Nat Rev Cancer,2006,6(11):857-866.
[6]  Zhou W,Hao M,Du X,et al.Advances in targeted therapy for osteosarcoma[J].Discov Med,2014,17(96):301-307.
[7]  Luetke A,Meyers PA,Lewis I,et al.Osteosarcoma treatment-where do we stand?A state of the art review[J].Cancer Treat Rev,2014,40(4):523-532.
[8]  Li D,Liu X,Lin L,et al.MicroRNA-99ainhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma[J].J Biol Chem,2011,286(42):36 677-36 785.
[9]  Hu Y,Zhu Q,Tang L.MiR-99aantitumor activity in human breast cancer cells through targeting of mTOR expression[J].PLoS One,2014,9(3):e92099.
[10]  Karaayvaz M,Pal T,Song B,et al.Prognostic significance of miR-215in colon cancer[J].Clin Colorectal Cancer,2011,10(4):340-347.
[11]  Mishra PJ,Merlino G.MicroRNA reexpression as differentiation therapy in cancer[J].J Clin Invest,2009,119(8):2 119-2 123.
[12]  Ma W,Zhang X,Chai J,et al.Circulating miR-148ais a significant diagnostic and prognostic biomarker for patients with osteosarcoma[J].Tumour Biol,2014,35(12):12 467-12 472.
[13]  Xu SH,Yang YL,Han SM,et al.MicroRNA-9expression is a prognostic biomarker in patients with osteosarcoma[J].World J Surg Oncol,2014,12:195.
[14]  Challagundla KB,Fanini F,Vannini I,et al.microRNAs in the tumor microenvironment:solving the riddle for a better diagnostics[J].Expert Rev Mol Diagn,2014,14(5):565-574.
[15]  Nedelcu D,Andreescu N,Boeriu E,et al.Retrospective study on osteosarcoma and ewing sarcoma-our experience[J].Maedica(Buchar),2014,9(2):151-156.
[16]  Hu H,Zhang Y,Cai XH,et al.Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts[J].Oncol Lett,2012,4(5):1 037-1 042.
[17]  Sempere LF,Korc M.A method for conducting highly sensitive microRNAin situ hybridization and immunohistochemical analysis in pancreatic cancer[J].Methods Mol Biol,2013,980:43-59.
[18]  Yu SH,Zhang CL,Dong FS,et al.miR-99asuppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1signaling pathway[J].J Cell Biochem,2015,116(2):268-276.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133